|
 |
| NSS |
|
Soares, H., Kumar, A., Serdarevic, F., Fiorica, J., Wells, R., Swann, S., Buckner, J., Sargent, D., Hozo, I. and Djulbegovic, B.: Equipoise Principle and NCI-Sponsored Clinical Trials: Are Investigators Truly Uncertain About Their Comparisons? Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 540s, Abs. #6050, 2005. |
|
other |
 |
| NSS |
|
Djulbegovic, B., Kumar, A., Soares, H., Serdarevic, F., Wells, R., Fiorica, J., Swann, S., Buckner, J., Sargent, D. and Hozo, I.: A Relationship Between Ethics of Clinical Trials and Therapeutic Advances in Cancer. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 550s, Abs. #6090, 2005. |
|
other |
|
| NSS |
|
Kumar, A., Soares, H., Serdarevic, F., Hozo, I., Buckner, J., Wells, R., Fiorica, J., Swann, S., Sargent, D. and Djulbegovic, B.: How Many New Treatments are "Breakthroughs"? Evaluation of Innovations in Cancer. Proc Am Soc Clin Oncol (ASCO), Orlando, FL, J Clin Oncol, [23] (16S) pg. 544s, Abs. #6066, 2005. |
|
other |
|
| NSS |
|
Young, B. K., Ley, J., Mitnick, S., Barror, N., Bergantz, W., Berkey, B. and Iyer, V.: Changing the Data Management Paradigm of a Long-Established Clinical Trials Cooperative Group. Soc Clinical Trials, Portland, Oregon, Controlled Clin Trials, [2] (1) pg. S27, Abs. #10, 2005. |
|
stat/informatics |
|
| NSS |
|
Young, B., Swann, S., Berkey, B., Motyka-Welsh, E., Caldwell, T. and King, S.: Enhancing the Organizational Efficiency of The Radiation Therapy Oncology Group Through a Continuous Quality Improvement Initiative. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S385-S386, Abs. #2266, 2005. |
|
informatics/stat |
|
| NSS |
|
Soares, H., Kumar, A., Daniels, S., Swann, S., Cantor, A., Hozo, I., Clark, M., Serdarevic, F., Gwede, C., Trotti, A. and Djulbegovic, B.: Evaluation of New Treatments in Radiation Oncology: Are they Better Than Standard Treatments? JAMA, 293 (8):970-1003, 2005. |
|
none |
|
| bone/mets |
|
Konski, A., DeSilvio, M., Hartsell, W., Watkins-Bruner, D., Coyne, J., Scarantinio, C. and Janjan, N.: Continuing Evidence for Poorer Treatment Outcomes for Single Male Patients: Re-Treatment Data from RTOG 97-14. Proc Amer Soc Thera Rad Onc (ASTRO), Denver, CO, Int J Radiat Oncol Biol Phys, [63] (Suppl. 1) pg. S192, Abs. #1079, 2005. |
9714 |
rt/outcomes |
|
| bone/mets |
|
Hartsell, W., Scott, C., Watkins Bruner, D., Scarantino, C., Ivker, R., Roach III, M., Suh, J., Demas, W., Movsas, B., Petersen, I., Konski, A., Cleeland, C., Janjan, N. and DeSilvio, M.: Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases. J Natl Cancer Inst (JNCI), 97 (11):798-804, 2005. |
9714 |
cacon |
|
| NSS |
|
Young, B., Welsh-Motyka, E., Swann, S. and King, S.: Developing Metrics For Cooperative Clinical Trials Group Data Management and Statistical Center. Soc Clinical Trials, New Orleans, LA, Controlled Clin Trials, [1] (2) pg. 247, Abs. #P35, 2004. |
|
stat/informatics |
|
| NSS |
|
Dicker, A.: Foreword: Epidermal Growth Factor Receptor (EGFR) Inhibitors and Cancer Therapeutics. Int J Radiat Onco Biol Phys, 58 (3):898, 2004. |
EGFR |
|
|
| NSS |
|
Dicker, A. and Rodeck, U.: Targeting the EGFR in Neoplasia — More Questions Than Answers. Int J Radiat Onco Biol Phys, 58 (3):899-902, 2004. |
EGFR |
|
|
| NSS |
|
Marmor, M. D., Skaria, K. and Yarden, Y.: Signal Transduction and Oncogenesis by ErbB/HER Receptors. Int J Radiat Onco Biol Phys, 58 (3):903-913, 2004. |
EGFR/ErbB/HER |
|
|
| NSS |
|
Viloria-Petit, A. and Kerbel, R.: Acquired Resistance to EGFR Inhibitors: Mechanisms and Prevention Strategies. Int J Radiat Onco Biol Phys, 58 (3):914-926, 2004. |
EGFR/HER |
|
|
| NSS |
|
Mass, R. D.: The HER Receptor Family: A Rich Target For Therapeutic Development. Int J Radiat Onco Biol Phys, 58 (3):932-940, 2004. |
EGFR/HER |
|
|
| NSS |
|
Ochs, J. S.: Rationale and Clinical Basis for Combining Gefitinib (IRESSA, ZD1839) with Radiation Therapy for Solid Tumors. Int J Radiat Onco Biol Phys, 58 (3):941-949, 2004. |
EGFR/IRESSA |
|
|
| NSS |
|
Milas, L., Fan, Z., Andratschke, N. H. and Ang, K. K.: Epidermal Growth Factor Receptor and Tumor Response to Radiation: In Vivo Preclinical Studies. Int J Radiat Onco Biol Phys, 58 (3):966-971, 2004. |
EGFR/C225 |
rt |
|
| NSS |
|
Harari, P. and Huang, S. M.: Combining EGFR Inhibitors With Radiation Or Chemotherapy: Will Preclinical Studies Predict Clinical Results? Int J Radiat Onco Biol Phys, 58 (3):976-983, 2004. |
EGFR |
chemo/rt |
|
| NSS |
|
Foon, K., Yang, X., Weiner, L., Belldegrun, A., Figlin, R., Crawford, J., Rowinsky, E., Dutcher, J., Vogelzang, N., Gollub, J., Thompson, J., Schwartz, G., Bukowski, R., Roskos, L. and Schwab, G.: Preclinical and Clinical Evaluations of ABX-EGF, A Fully Human Anti-Epidermal Growth Factor Receptor Antibody. Int J Radiat Onco Biol Phys, 58 (3):984-990, 2004. |
EGFR/ABX-EGF |
|
|
| NSS |
|
Dancey, J.: Epidermal Growth Factor Receptor Inhibitors in Clinical Development. Int J Radiat Onco Biol Phys, 58 (3):1003-1007, 2004. |
EGFR |
|
|
| NSS |
|
Konski, A. and Watkins-Bruner, D.: The RTOG Outcomes Model: Economic Endpoints and Measures. Expert Opin Pharmacoeconomics, 5 (3):513-519, 2004. |
multi |
Outcomes/ECON |
|
| NSS |
|
Watkins-Bruner, D., Movsas, B., Konski, A., Roach III, M., Bondy, M., Scarantinio, C., Scott, C. and Curran Jr, W.: Outcomes Research in Cancer Clinical Trial Cooperative Groups: The RTOG Model. Quality of Life Research, 13 (6):1025-1041, 2004. |
Outcomes/QOL |
|
|
| bone/mets |
|
Hartsell, W., DeSilvio, M., Watkins-Bruner, D., Scarantinio, C., Ivker, R., Roach III, M., Suh, J., Seider, M., Movsas, B., Petersen, I. and Konski, A.: Can Physicians Accurately Predict Survival Time In Patients With Metastatic Cancer? Analysis of RTOG 97-14. Proc Amer Soc Thera Rad Onc (ASTRO), Atlanta, GA, Int J Radiat Oncol Biol Phys, [60] (1) pg. S143-144, Abs. #25, 2004. |
9714 |
cacon |
|
| bone/mets |
|
Watkins-Bruner, D., Winter, K., Hartsell, W., Konski, A., Curran Jr, W., Roach III, M., Doncals, D., Movsas, B., Lee, D. and Scarantinio, C.: Prospective Health-Related Quality of Life Valuations (Utilities) of 8 Gy in 1 Fraction vs. 30 Gy in 10 Fractions for Palliation of Painful Bone Metastases: Preliminary Results of RTOG 97-14. Proc Amer Soc Thera Rad Onc (ASTRO), Atlanta, GA, Int J Radiat Oncol Biol Phys, [60] (1) pg. S142, Abs. #23, 2004. |
9714 |
Outcomes/QOL |
|
| non-specific site |
|
Soares, H., Kumar, A., Daniels, S., Sargent, D., Buckner, J., Swann, S., Smith, R., Khyayat, A., Wells, R. and Djulbegovic, B.: Lack of Publication bias in Randomized Clinical Trials (RCTs) Sponsored by the National Cancer Institute (NCI) and Performed by Cooperative Oncology Groups (COGs). Proc Am Soc Clin Oncol (ASCO), New Orleans, LA, J Clin Oncol, [23] (June 5-8, 2004) pg. 518, Abs. #6004, 2004. |
NSS |
|
|
| non-specific site |
|
Dicker, A.: Foreword: Epidermal Growth Factor Receptor (EGFR) Inhibitors and Cancer Therapeutics. Int J Radiat Onco Biol Phys, 58 (3):898, 2004. |
NSS |
EGFR |
|
| non-specific site |
|
Dicker, A. and Rodeck, U.: Targeting the EGFR in Neoplasia — More Questions Than Answers. Int J Radiat Onco Biol Phys, 58 (3):899-902, 2004. |
NSS |
EGFR |
|
| non-specific site |
|
Marmor, M. D., Skaria, K. and Yarden, Y.: Signal Transduction and Oncogenesis by ErbB/HER Receptors. Int J Radiat Onco Biol Phys, 58 (3):903-913, 2004. |
NSS |
EGFR/ErbB/HER |
|
| non-specific site |
|
Viloria-Petit, A. and Kerbel, R.: Acquired Resistance to EGFR Inhibitors: Mechanisms and Prevention Strategies. Int J Radiat Onco Biol Phys, 58 (3):914-926, 2004. |
NSS |
EGFR/HER |
|
| non-specific site |
|
Mass, R. D.: The HER Receptor Family: A Rich Target For Therapeutic Development. Int J Radiat Onco Biol Phys, 58 (3):932-940, 2004. |
NSS |
EGFR/HER |
|
| non-specific site |
|
Ochs, J. S.: Rationale and Clinical Basis for Combining Gefitinib (IRESSA, ZD1839) with Radiation Therapy for Solid Tumors. Int J Radiat Onco Biol Phys, 58 (3):941-949, 2004. |
NSS |
EGFR/IRESSA |
|
| non-specific site |
|
Milas, L., Fan, Z., Andratschke, N. H. and Ang, K. K.: Epidermal Growth Factor Receptor and Tumor Response to Radiation: In Vivo Preclinical Studies. Int J Radiat Onco Biol Phys, 58 (3):966-971, 2004. |
NSS |
EGFR/C225
rt |
|
| non-specific site |
|
Harari, P. and Huang, S. M.: Combining EGFR Inhibitors With Radiation Or Chemotherapy: Will Preclinical Studies Predict Clinical Results? Int J Radiat Onco Biol Phys, 58 (3):976-983, 2004. |
NSS |
EGFR
chemo/rt |
|
| non-specific site |
|
Foon, K., Yang, X., Weiner, L., Belldegrun, A., Figlin, R., Crawford, J., Rowinsky, E., Dutcher, J., Vogelzang, N., Gollub, J., Thompson, J., Schwartz, G., Bukowski, R., Roskos, L. and Schwab, G.: Preclinical and Clinical Evaluations of ABX-EGF, A Fully Human Anti-Epidermal Growth Factor Receptor Antibody. Int J Radiat Onco Biol Phys, 58 (3):984-990, 2004. |
NSS |
EGFR/ABX-EGF |
|
| non-specific site |
|
Konski, A. and Watkins Bruner, D.: The RTOG Outcomes Model: Economic Endpoints and Measures. Expert Opin Pharmacoeconomics, 5 (3):513-519, 2004. |
multi |
NSS
ECON |
|
| bone/mets |
|
Hartsell, W., Scott, C., Watkins Bruner, D., Scarantinio, C., Ivker, R., Roach III, M., Suh, J., Demas, W., Movsas, B., Petersen, I. and Konski, A.: Phase III Randomized Trial of 8 Gy in 1 Fraction vs. 30 Gy in 10 Fractions for Palliation of Painful Bone Metastases: Preliminary Results of RTOG 97-14. Proc Am Soc Thera Rad Oncol (ASTRO), Salt Lake City, UT, Int J Radiat Oncol Biol Phys, [57] (2) pg. S124, Abs. #1, 2003. |
9714 |
bone/mets
cacon |
|
| misc |
|
Soares, H., Daniels, S., Kumar, A., Clarke, M., Scott, C., Swann, S. and Djulbegovic, B.: Bad Reporting Does Not Mean Bad Methods For Randomized Trials:Observational Study Of Randomized Controlled Trials Performed By The Radiation Therapy Oncology Group. British Medical Journal, 328 (1):22-25, 2004. |
NSS |
|
|
| misc |
|
Djulbegovic, B., Soares, H., Daniels, S., Scott, C., Kumar, A., Gwede, C., Cantor, A. and Clarke, M.: Evaluation of New Treatments in Cancer: Are They Better Than Standard Treatments? Proc 11th Cochrane Colloquium, Barcelona, Spain, Libro De Resumenes, pg. 27, Abs. #49, 2003. |
NSS |
|
|
| misc |
|
Chapman, J., Bradley, J., Eary, J., Haubner, R., Larson, S., Michalski, J., Okunieff, P., Strauss, H., Ung, Y. and Welch, M.: Molecular (Functional) Imaging for Radiotherapy Applications: An RTOG Symposium. 55 (2):294-301, 2003. |
NSS |
Ki-67/p105
other (imaging) |
|
| misc |
|
Scott, C.: Statistical Issues in Studies of Toxicity Modifiers. Sem in Rad Oncol, 12 (1 (Suppl 1)):91-96, 2002. |
NSS |
stat |
|
| misc |
|
Trotti, A.: The Evolution and Application of Toxicity Criteria. Sem in Rad Oncol, 12 (1 (Suppl 1)):1-3, 2002. |
NSS |
lateff |
|
| misc |
|
Cella, D., Bullinger, M., Scott, C., Barofsky, I. and Group, C. S. C. M.: Group vs Individual Approaches to Understanding the Clinical Significance of Differences or Changes in Quality of Life. Mayo Clinc Proc, 77 (4):384-392, 2002. |
NSS |
QOL |
|
| misc |
|
Sloan, J., Aaronson, N., Cappelleri, J. C., Fairclough, D. L., Varricchio, C. and Scott, C. C. S. C. M. G.: Assessing the Clinical Significance of Single Items Relative to Summated Scores. Mayo Clinc Proc, 77 (5):479-487, 2002. |
NSS |
QOL |
|
| misc |
|
Frost, M. F., Bonomi, A. E., Ferrans, C., Wong, G., Hays, R. D. and Scott, C. C. S. C. M. G.: Patient, Clinician, and Population Perspectives on Determining the Clinical Significance of Quality-of-Life Scores. Mayo Clinc Proc, 77 (5):488-494, 2002. |
NSS |
QOL |
|
| misc |
|
Guyatt, G., Osoba, D., Wu, A., Wyrwich, K., Norman, G. and Scott, C. C. S. C. M. G.: Methods to Explain the Clinical Significance of Health Status Measures. Mayo Clinc Proc, 77 (4):371-383, 2002. |
NSS |
QOL |
|
| misc |
|
Sloan, J., Cella, D., Frost, M. F., Guyatt, G., Sprangers, M., Symonds, T. and Scott, C. C. S. C. M. G.: Assessing Clinical Significance in Measuring Oncology Patient Quality of Life: Introduction to the Symposium, Content Overview, and Definition of Terms. Mayo Clinc Proc, 77 (4):367-370, 2002. |
NSS |
QOL |
|
| misc |
|
Sprangers, M., Moinpour, C. M., Moynhan, T., Patrick, D., Revicki, D. and Scott, C. C. S. C. M. G.: Assessing Meaningful Change in Quality of Life Over Time: A Users' Guide for Clinicians. Mayo Clinc Proc, 77 (6):561-571, 2002. |
NSS |
QOL |
|
| misc |
|
Symonds, T., Berzon, R., Marquis, P., Rummans, T. and Scott, C. C. S. C. M. G.: The Clinical Significance of Quality-of-Life Results: Practical Considerations for Specific Audiences. Mayo Clinc Proc, 77 (6):572-583, 2002. |
NSS |
QOL |
|
| Lymph |
|
Ambinder, R., Lee, S., Curran, W., Sparano, J., Krigel, R., McArthur, J., Schultz, C., Freter, C., Kaplan, L. and VonRoenn, J.: Phase II Intergroup Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma. Cancer Therapy, 1 215-221, 2003. |
9416 |
lymph
chemo |
|
bone/
soft tissue |
|
Kraybill, W., Harris, J., Spiro, I., Ettinger, D., Trotti, A., Lucas, D., Blum, R., Letson, D. and Eisenberg, B.: Radiation Therapy Oncology Group (RTOG) 9514: A Phase II Study of Neoadjuvant Chemotherapy (CT) and Radiation Therapy (RT) in the Management Of High Risk (HR), High Grade, Soft Tissue Sarcomas (STS) of the Extremities And Body Wall. Proceeding from Am Soc Clin Oncol (ASCO), Chicago, IL, J Clin Oncol, [22] (May 31-June 3, 2003) pg. 815, Abs. #3276, 2003. |
9514 |
bone/soft tissue
surg/rt/chemo |
|
lung/hn/
gu/gi/gyn |
|
Curran, W.: New Chemotherapeutic Agents: Update of Major Chemoradiation Trials in Solid Tumors. Oncol, 63 (2 Suppl):29-38, 2002. |
multi |
chemo |
|
gu/prostate,
CNS/brain,hn |
|
Milanes-Yearsley, M., Hammond, E., Pajak, T., Cooper, J., Chang, C., Griffin, T., Nelson, D., Laramore, G. and Pilepich, M.: Tissue Micro-Array: A Cost and Time-Effective Method for Correlative Studies by Regional and National Cancer Study Groups. Mod Pathol, Dec.15 (12):1366-1373, 2002. |
lab corr study |
path |
|
| hn, gi/upper, lung, gi/lower, gu/prostate |
9003, 9405 |
Movsas, B., Scott, C. and Bruner, D.: Pre-Treatment Factors Significantly Influence Quality Of Life In Cancer Patients: A Radiation Therapy Oncology Group (RTOG) Analysis. Proceeding from Int Soc Qual of Life Research (ISOQOL), Orlando, FL, Quality of Life Research, pg. 623, Abs. #9, 2002. |
9003, 9405, 8901, 9401, 9020 |
QOL |
|
| bone/soft tissue |
|
Kraybill, W., Spiro, I., Harris, J., Ettinger, D., Trotti, A., Lucas, D., Blum, R. and Eisenberg, B.: RTOG 95-14: A Phase II Study of Neoadjuvant Chemotherapy (CT) and Radiation Therapy (RT) in the Management of High Risk, High Grade, Soft Tissue Sarcomas (STS) of the Extremities and Body Wall: A Preliminary Report. Connective Tissue Onc Soc (CTOS), Palm Beach, FL, Sarcoma, 5(November 2001): pg. Abs. #Poster, 2001. |
9514 |
surg/rt/chemo |
|
| bone |
|
Kraybill, W., Spiro, I., Harris, J., Ettinger, D., Trotti, A., Lucas, D., Blum, R. and Eisenberg, B.: Radiation Therapy Oncology Group (RTOG) 95-14: a Phase II Study of Neoadjuvant Chemotherapy (CT) and Radiation Therapy (RT) in High Risk (HR), High Grade, Soft Tissue Sarcomas (STS) of the Extremities and Body Wall: a Preliminary Report. Proceeding from Am Soc Clin Oncol (ASCO), San Francisco, CA, J Clin Oncol, 20 #1387, 348a, 2001. |
9514 |
surg/rt/chemo |
|
| misc |
|
Scott, C., Scarantino, C., Watkins Bruner, D., Fu, K., Shipley, W. and Cooper, J.: Late Effects of Normal Tissue in Head and Neck and Prostate Cancer Patients Treated with Radiation Therapy. Res Issues in Canc Survivorship (NCI Workshop), Bethesda, MD, pg. Abs. 1998. |
|
QOL |
|
| misc |
|
Wasserman, T., Scott, C., Bruner, D., Fisher, J., Riese, N., Allaster, R. and Leonard, B.: Quality of Life Research in the Radiation Therapy Oncology Group (RTOG). Am Radium Soc (ARS), Monte Carlo, Monaco, Proceedings Amer Rad Soc, [May 2-6], pg. Abs. 1998. |
|
QOL |
|
| misc |
|
Scott, C. and Wasserman, T.: When is a Negative Study Not Negative? Int J Radiat Oncol Biol Phys, 39(4):859-861, 1997. |
|
stat |
|
| misc |
|
Chamberlain, R. M., Porter, A., Vijayakumar, S., Winter, K. and Bondy, M. L.: Sociodemographic Analysis of Patients in Radiation Therapy Oncology Group Clinical Trials. Int J Radiat Oncol Biol Phys, 40(1):9-15, 1998. |
|
|
|
| misc |
|
Wasserman, T., Scott, C., Bruner, D., Fisher, J., Riese, N., Allaster, R. and Leonard, B.: A Successful Group Quality of Life Programme: Radiation Therapy Oncology Group (RTOG). ISOQOL, Vienna, Austria, Quality of Life Research, [6], pg. 739-740, Abs. #418, 1997. |
|
QOL |
|
| |
|
Suntharalingam, N. and Cox, J. D.: Radiation Oncology Quality Assurance in RTOG Protocol Studies - Physical Aspects. ISRO/IAEA, 1995. |
|
QA |
|
| |
|
Mittal, B. B., Scott, C. B., Myerson, R. J., Sapozink, M. D. and Samulski, T. V.: A Phase I/II Study to Evaluate Radiation Therapy and Hyperthermia for Deep-Seated Tumors: A Report of RTOG 89-08. International Congress of Hyperthermia Oncology, Rome, [4016/pending], 1996. |
8908 |
hta |
|
| bone |
|
Scarantino, C., Caplan, R., Rotman, M., Coughlin, C., Demas, W. and DelRowe, J.: A Phase I/II Study to Evaluate the Effect of Fractionated Hemibody Irradiation in the Treatment of Osseous Metastases - RTOG 88-22. Int J Radiat Oncol Biol Phys, 36(1):37-48, 1996. |
8822 |
lgfld/td |
|
| bone |
|
Eifel, P. J., Donaldson, S. S. and Thomas, P. R.: Response of Growing Bone to Irradiation: A Proposed Late Effects Scoring System. Int J Radiat Oncol Biol Phys, 31(5):1301-1307, 1995. |
|
lateff |
|
| bone |
|
Scarantino, C., Caplan, R., Rotman, M., Coughlin, C., Demas, W. and DelRowe, J.: A Phase I/II Study to Evaluate the Effect of Fractionated Hemibody Irradiation in the Treatment of Osseous Bone Metastases - RTOG 88-22. Proc Am Soc Thera Radiol Oncol (ASTRO), Miami Beach, FL, Int J Radiat Oncol Biol Phys, 32 (Supplement 1):167, [52], 1995. |
8822 |
td/lgfld |
|
| bone/mets |
|
Poulter, C., Cosmatos, D., Rubin, P., Urtasun, R., Cooper, J., Kuske, R., Hornback, N., Coughlin, C., Weigensberg, I. and Rotman, M.: A Report of RTOG 82-06: A Phase III Study of Whether the Addition of Single Dose Hemibody Irradiation to Standard Fractionated Local Field Irradiation is More Effective Than Local Field Irradiation Alone in the Treatment of Symptomatic Osseous Mets. Int J Radiat Oncol Biol Phys, 23(1):207-214, 1992. |
8206 |
lgfld |
|
bone/
soft tissue |
|
Kiel, K., Witt, T., Krall, J., Noyes, D., Sause, W., Lanciano, R., Thomson, J. and Hanks, G.: Final Results of RTOG 85-07: Phase II Study of Intraoperative Radiation for Retroperitoneal Sarcomas. Intraoperative Radiation Therapy, Proceedings of 4th Interntl Symposium IORT):430-435, 1993. |
8507 |
IORT/surg |
|
| breast |
|
Janjan, N., Graves, M., Hanson, W. F. and Fowble, B.: Comparison of Ideal and Actual Target Volumes with Interstitial Implant Boost for T1, T2, N0 Breast Cancer: Analysis of RTOG 83-06. Proc Am Soc Thera Radiol Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, 27 (3):271-272, [1044], 1993. |
8306 |
brachy/td |
|
| lymph |
|
Vriesendorp, H., Herpst, J., Germack, M., Klein, J., Leichner, P., Loudenslager, D. and Order, S.: Phase I-II Studies of Yttrium-Labeled Anti-Ferritin Treatment for End-Stage Hodgkin's Disease, Including RTOG 87-01. J Clin Oncol, 9(6):918-928, 1991. |
8701 |
radiopharm |
|
| NSS |
|
Emami, B., Stauffer, P., Dewhirst, M., Prionas, S., Ryan, T., Corry, P., Herman, T., Kapp, D., Myerson, R., Samulski, T., Sapareto, S., Sapozink, M., Shrivastava, P. and Waterman, F.: RTOG Quality Assurance Guidelines for Interstitial Hyperthermia. Int J Radiat Oncol Biol Phys, 20:1117-1124, 1991. |
|
hta/QA |
|
| NSS |
|
Emami, B., Gibbs, F., Lee, C., Scott, C., Myerson, R. and Perez, C.: Phase I/II Study, Combination of Radiotherapy and Hyperthermia in Patients with Deep-Seated Malignant Tumors: Report of a Pilot Study by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys, 20:73-79, 1991. |
8401 |
hta |
|
| NSS |
|
Fu, K., Cox, J., Pajak, T., Nelson, D., Sause, W., Spanos, W., Russell, A., Marcial, V. and Komaki, R.: RTOG Altered Fractionation Trials. Ninth International Congress of Radiation Research, Volume II:567-572, 1991. |
|
td |
|
| NSS |
|
Wasserman, T., Bruner, D. and Scott, C.: Radiation Therapy Oncology Group (RTOG). J Natl Cancer Inst Monographs, 20:81-82, 1996. |
|
QOL |
|
| NSS |
|
Cox, J. D.: Evolution and Accomplishments of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys, 33(3):747-754, 1995. |
|
admin |
|
| NSS |
|
Scott, C.: Quality of Life in the Radiation Therapy Oncology Group. Quality of Life Newsletter, Feb-May(#9):2, 1994. |
|
QOL/meth |
|
| NSS |
|
Caplan, R., Pajak, T. and Cox, J.: In Response to Dr. Denham Et. Al. Int J Radiat Oncol Biol Phys, 35(1):197, 1996. |
|
stat |
|
| NSS |
|
Wasserman, T. and McDonald, A.: Quality of Life: The Patient's Endpoint. Int J Radiat Oncol Biol Phys, 33(4):965-966, 1995. |
9020 |
QOL |
|
| NSS |
|
Emami, B., Scott, C., Perez, C., Asbell, S., Swift, P., Grigsby, P., Montesano, A., Rubin, P., Curran, W., Delrowe, J., Arastu, H., Fu, K. and Moros, E.: Phase III Study of Interstitial Thermoradiotherapy Compared with Interstitial Radiotherapy Alone in the Treatment of Recurrent or Persistent Human Tumors: A Prospectively Controlled Randomized Study by the Radiation Therapy Oncology Group. Proc Am Soc Thera Radiol Oncol (ASTRO), New Orleans, LA, Int J Radiat Oncol Biol Phys, 27 155, [47], 1993. |
8419 |
hta/brachy |
|
| NSS |
|
Caplan, R., Pajak, T. and Cox, J.: Analysis of the Probability and Risk of Cause-Specific Failure. Int J Radiat Oncol Biol Phys, 29(No. 5):1183-1186, 1994. |
|
stat |
|
| NSS |
|
Diener-West, M., Pajak, T., Bauer, M. and Cox, J.: Randomized Dose Searching Phase ILE/II Trials of Fractionation in Radiation Therapy for Cancer. J Natl Cancer Inst, 83(15):1065-1071, 1991. |
|
td/meth |
|
| NSS |
|
Moros, E., Scott, C., Emami, B., Perez, C., Asbell, S., Swift, P., Grigsby, P., Montesano, A., Rubin, P., Curran, W., Delrowe, J., Arastu, H. and Fu, K.: Adequacy of Treatment Analysis of an Interstitial Thermoradiotherapy Study (RTOG 84-19). Radiation Research Society/North American Hyperthermia Society, Nashville, TN, Proceedings of 14th Annual Meeting of North American Hyperthermia Society, 110, [P01-13], 1994. |
8419 |
hta/QA |
|
| NSS |
|
Sause, W., Cooper, J., Rush, S., Ago, C., Cosmatos, D., Coughlin, C., Janjan, N. and Lipsett, J.: Fraction Size in External Beam Radiation Therapy in the Treatment of Melanoma. Int J Radiat Oncol Biol Phys, 20(3):429-432, 1991. |
8305 |
td |
|
| NSS |
|
Scott, C. and Stetz, J.: Design, Analysis and Data Management Issues in Quality of Life Trials (QOL) Within the Radiation Therapy Oncology Group (RTOG). Drug Information Association, Charleston, SC, Drug Information Journal, 27 (3):854-855, 1993. |
|
meth/stat/QOL |
|
| NSS |
|
Sapozink, M., Corry, P., Kapp, D., Myerson, R., Dewhirst, M., Emami, B., Herman, T., Prionas, S., Ryan, T., Samulski, T., Sapareto, S., Shrivastava, P., Stauffer, P. and Waterman, F.: RTOG Quality Assurance Guidelines for Clinical Trials Using Hyperthermia for Deep-Seated Malignancy. Int J Radiat Oncol Biol Phys, 20:1109-1115, 1991. |
|
hta/QA |
|
| NSS |
|
Scott, C. B., Stetz, J., Bruner, D. W. and Wasserman, T. H.: Radiation Therapy Oncology Group Quality of Life Assessment: Design, Analysis, and Data Management Issues. Quality of Life Research, 3:199-206, 1994. |
|
stat/meth/QOL |
|
| NSS |
|
Scott, C. B., Stetz, J., Bruner, D. W. and Wasserman, T. H.: Design, Analysis, and Data Management Issues in Quality of Life Trials Within the Radiation Therapy Oncology Group. Clinical Trials in Oncology: Improving Their Design and Analysis, Toronto, Ontario, 53, 1993. |
|
QOL/stat/meth |
|
| NSS |
|
Perez, C. A., Scott, C., Emami, B., Hornback, N. B., Sneed, P. K., Asbell, S. O. and Janjan, N. A.: Evaluation of 45°C Hyperthermia and Irradiation. II. A Phase I Clinical Trial in Humans by the Radiation Therapy Oncology Group. Am J Clin Oncol (CCT), 16(6):477-481, 1993. |
8705 |
hta |
|
| NSS |
|
Cox, J. D., Stetz, J. and Pajak, T. F.: Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 31(5):1341-1346, 1995. |
|
meth/QA |
|
| NSS |
|
Perez, C., Pajak, T., Emami, B., Hornback, N., Tupchong, L. and Rubin, P.: Randomized Phase III Study Comparing Irradiation and Hyperthermia with Irradiation Alone in Superficial Measurable Tumors. Final Report by the Radiation Therapy Oncology Group. Am J Clin Oncol (CCT), 14(2):133-141, 1991. |
8104 |
hta |
|
| NSS |
|
Pajak, T.: Methodology of Clinical Trials. In Principles and Practice of Radiation Oncology (Perez, C. and LW, B., ed.) J.B. Lippincott Company, Philadelphia, pg. 173-182, 2nd, 1992. |
|
stat |
|
| NSS |
|
Waterman, F., Dewhirst, M., Fessenden, P., Samulski, T., Stauffer, P., Emami, B., Corry, P., Prionas, S., Sapozink, M., Herman, T., Kapp, D., Myerson, R., Ryan, T., Sapareto, S. and Shrivastava, P.: RTOG Quality Assurance Guidelines for Clinical Trials Using Hyperthermia Administered by Ultrasound. Int J Radiat Oncol Biol Phys, 20:1099-1107, 1991. |
|
hta/QA |
|
| NSS |
|
Cox, J.: Brief History of Comparative Clinical Trials in Radiation Oncology: Perspectives From the Silver Anniversary of the Radiation Therapy Oncology Group. Radiol, 192(1):25-32, 1994. |
|
admin |
|
| NSS |
|
Wasserman, T., Phillips, T., Hanks, G., Order, S., Perez, C., Pajak, T., Pakuris, E., Brady, L., Leibel, S. and Cox, J.: The Radiation Therapy Oncology Group: An uUpdate of Clinical Research Activities. Int J Radiat Oncol Biol Phys, 20:1383-1391, 1991. |
|
admin |
|
| NSS |
|
Curran, W., Pajak, T., Emami, B., Fu, K., McKenna, W., Rubin, P., Byhardt, R., Cooper, J., Abrams, R., Asbell, S., Russell, A., Sause, W. and Cox, J.: Lessons from Our Past: Analysis of Patient Accrual Patterns in Radiation Therapy Oncology Group (RTOG) Clinical Trials from 1968 to 1992. ARS (95), Paris, France, Proceedings of the American Radium Society 78th Annual Meeting, April 29-May 3 (meeting dates) 35, [75], 1995. |
|
admin/meth |
|
| NSS |
|
Shaw, E., Kline, R., Gillin, M., Souhami, L., Hirschfeld, A., Dinapoli, R. and Martin, L.: Radiation Therapy Oncology Group: Radiosurgery Quality Assurance Guidelines. Int J Radiat Oncol Biol Phys, 27:1231-1239, 1993. |
|
QA/SRS |
|
| NSS |
|
Emami, B., Scott, C., Perez, C., Asbell, S., Swift, P., Grigsby, P., Montesano, A., Rubin, P., Curran, W., DelRowe, J., Arastu, H., Fu, K. and Moros, E.: Phase III Study of Interstitial Thermoradiotherapy Compared with Interstitial Radiotherapy Alone in the Treatment of Recurrent or Persistent Human Tumors: A Prospectively Controlled Randomized Study by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys, 34(5):1097-1104, 1996. |
8419 |
hta/brachy |
|
| NSS |
|
Purdy, J. A., Harris, W. B., Michalski, J. M., Bosch, W., Cox, J. D., Phillips, T. L. and Verhey, L. J.: Radiation Therapy Oncology Group: 3-D CRT Quality Assurance Guidelines. Proc Am Soc Thera Radiol Oncol (ASTRO), Miami Beach, FL, Int J Radiat Oncol Biol Phys, 32 (Supplement 1):306, [2090], 1995. |
9406 |
3D |
|
| NSS |
|
Turner, M. and Stetz, J.: Computer Generated Electronic Mail in Clinical Trials. Society for Clinical Trials, Orlando, Florida, [P14], 1993. |
|
meth/admin |
|
| NSS |
|
Scott, C. and Farnan, N.: Quality Adjusted Survival in Patients with Chronic Symptoms. International Biometrics Conference, Hamilton, Ontario CANADA, Proceedings of the XVIIth International Biometric Conference, 2 65, 1994. |
|
stat |
|
| NSS |
|
Myerson, R. J., Scott, C. B., Emami, B., Sapozink, M. D. and Samulski, T. V.: A Phase I/II Study to Evaluate Radiation Therapy and Hyperthermia for Deep-Seated Tumors: A Report of RTOG 89-08. Int J Hyperthermia, 12(4):449-459, 1996. |
8908 |
hta |
|
| NSS |
|
Watkins-Bruner, D.: In Search of the "Quality" in Quality-of-Life Research. Int J Radiat Oncol Biol Phys, 31(1):191-192, 1995. |
|
QOL |
|
| NSS |
|
Gaspar, L., Nag, S., Orton, C., Fu, K. and Porter, A.: Radiation Therapy Oncology Group (RTOG) Institutional Survey of Brachytherapy Practice: Implication for Future Development of RTOG Trials. Clinical Trials in Oncology: Improving Their Design and Analysis, Toronto, Ontario, 59, 1993. |
|
meth/brachy |
|
| NSS |
|
Fu, K. K., Ang, K. K. and Cox, J. D.: Radiation Therapy Oncology Group (RTOG) Altered Fractionation Trials. J Thera Radiol Oncol (Taiwan), 1995. |
|
td |
|
| NSS |
|
Turner, M. W. and Cooper, J. S.: Computer Assisted Quality Control of the Publication Process for a Clinical Cooperative Group: The RTOG Model. Society for Clinical Trials, Houston, Texas, Control Clin Trials, 15 (3S):76S, [66A], 1994. |
|
admin/QA |
|
| NSS |
|
Fu, K. K., Cox, J. D., Pajak, T. F., Nelson, D. F., Sause, W. T., Spanos, W. J., Russell, A. H., Marcial, V. A. and Komaki, R.: Clinical Experiences in Multi-Institutional Trials - RTOG. European Conference on Clinical Oncology in Cancer Nursing, Jerusalem, S43, [208], 1993. |
|
admin/meth |
|
| NSS |
|
Fawcett, S.-c. W.: Log-rank Statistic for Testing Interaction Effect in a 2x2 Factorial Design and Its Use in Sample Size Determination. Society for Clinical Trials, Houston, Texas, Control Clin Trials, 15 (3S):32S-33S, [02], 1994. |
|
stat |
|
| NSS |
|
Fu, K., Cox, J., Pajak, T., Nelson, D., Sause, W., Spanos, W., Russell, A., Marcial, V. and Komaki, R.: RTOG Altered Fractionation Trials. Proceedings, 9th Int'l Congress of Radiation Research, Academic Press, 2:567-572, 1992. |
|
td |
|
| NSS |
|
Rubin, P., Constine, L. S., Fajardo, L. F., Phillips, T. L., Wasserman, T. H., Bartelin, H., Denekamp, J., Horiot, J.-C., Mornex, F., Overgaard, J. and Pavy, J.-J.: Joint Statement of Mission by the RTOG/EORTC Working Groups. Int J Radiat Oncol Biol Phys, 31(5):1037-1039, 1995. |
|
lateff |
|
| NSS |
|
Noyes, R., Krall, J., Sause, W., Owens, J., Wolkov, H., Lanciano, R., Hanks, G. and Hoffman, J.: Surgical Complications of Intraoperative Radiation Therapy -- The Radiation Therapy Oncology Group Experience. J Surg Oncol, 50:209-215, 1992. |
|
surg/IORT |
|
| NSS |
|
Martin, L., Krall, J., Cox, J. and Leibel, S.: Influence of a Sampling Review Process of Radiotherapy Quality Assurance in Cooperative Group Clinical Trials - Results of the Radiation Therapy Oncology Group Analysis. European Society for Therapeutic Radiology and Oncology, Radiother Oncol, 24 (S):S44, [166], 1992. |
|
QA/stat |
|
| NSS |
|
Rubin, P., Constine, L., S, Fajardo, L., Phillips, T. and Wasserman, T.: Overview: Late Effects of Normal Tissues (LENT) Scoring System. Int J Radiat Oncol Biol Phys, 31(5):1041-1042, 1995. |
|
lateff |
|
| NSS |
|
Caplan, R. J., Pajak, T. and Cox, J. D.: In Response to Bentzen et al., IJROBP 32:1531-1534; 1995. Int J Radiat Oncol Biol Phys, 32(5):1547, 1995. |
|
stat |
|
| NSS |
|
Scott, C. B. and Pajak, T. F.: LENT: A Good Beginning but..... Int J Radiat Oncol Biol Phys, 31(5):1347-1348, 1995. |
|
lateff/meth |
|
| NSS |
|
Martin, L., Krall, J., Curran, W., Leibel, S. and Cox, J.: Influence of a Sampling Review Process for Radiation Oncology Quality Assurance in Cooperative Group Clinical Trials - Results of the Radiation Therapy Oncology Group (RTOG) Analysis. Radiother Oncol, 36:9-14, 1995. |
|
QA/stat |
|
| NSS |
|
Watkins-Bruner, D. and Wasserman, T.: The Impact on Quality of Life by Radiation Late Effects. Int J Radiat Oncol Biol Phys, 31(5):1353-1355, 1995. |
|
QOL/lateff |
|
|
|
